Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight...

WEDNESDAY, Jan. 22, 2025 -- Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with...

The Biden administration said Friday it is targeting 15 drugs in the second-ever round of price negotiations under Medicare, with blockbuster drugs...

WEDNESDAY, Jan. 22, 2025 -- With a sweep of the pen, President Donald Trump has ended a Biden administration effort to lower the cost of prescription...

Times: Could 'bespoke' weight-loss drugs be the future?

Clinical trials are finding amazing impacts of new versions of the drugs.

The impact of Ozempic and other GLP-1 receptor agonists like Wegovy, Mounjaro, and Zepbound on the alcohol and wine industry appears to be...

If public opinion polls are the guide, Joe Biden has been the worst president since Richard Nixon. Yet New York Times economics writer Peter Coy...

The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may pose heightened risks for...

New research into widely used weight loss drugs, including Ozempic, reveals significant health risks. These drugs, initially developed for diabetes...